VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Antiviral effect of the RIG-I agonist, Inarigavir | Nezam AfdahlView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Session 3 Panel discussionView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Rationale for Modulating Adaptive Immunity | Robert ThimmeView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Full title: Immune reconstitution with current available antiviral therapies: a baseline to gauge new immunotherapies | Andre BoonstraView Video
HJHarry JanssenMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018What is the cure rate with current therapies? | Harry Janssen, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Combination treatment of a TLR7 agonist RO7020531 and a core protein allosteric modulator RO7049389 achieved sustainable viral load suppression and HBsAg loss in an AAV-HBV mouse model | Yonghong ZhuView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Establishing functional control of HBV and HDV infection with REP 2139-based combination therapy | Andrew VaillantView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Clinical update on reducing HBV virus and antigen production using RNAi | Bruce GivenView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Clinical update, antiviral effect and mode of action of capsid assembly modulators | Jeysen YogaratnamView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Session 4 Panel discussionView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Targeting HBV Core Protein to Clear Infection and Achieve Higher Cure Rates | Richard ColonnoView Video
SUStephan UrbanPhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2018Clinical progress of the entry inhibitor Myrcludex B | Stephan UrbanView Video
